Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2019, Article ID 3024630, 8 pages
https://doi.org/10.1155/2019/3024630
Research Article

Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging

1Department of Radiology, General Hospital ZZKE, Košice 04001, Slovakia
2Department of Infectology and Travel Medicine, Faculty of Medicine, University of P. J. Safarik, Košice 04001, Slovakia
31st Department of Internal Medicine, Faculty of Medicine, University of P. J. Safarik, Košice 04001, Slovakia
4Department of Radiology, General Hospital, Trebišov 04001, Slovakia

Correspondence should be addressed to Pavol Kristian; ks.plnu@naitsirk

Received 19 September 2018; Revised 28 November 2018; Accepted 7 March 2019; Published 1 April 2019

Guest Editor: Tamara Milovanovic

Copyright © 2019 René Hako et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Tsochatzis, J. Bosch, and A. K. Burroughs, “Liver cirrhosis,” The Lancet, vol. 383, no. 9930, pp. 1749–1761, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Watanabe, M. Kanematsu, S. Goshima et al., “Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted mr imaging - preliminary observations,” Radiology, vol. 259, no. 1, pp. 142–150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Jarcuska, M. Janicko, E. Veselíny, P. Jarcuska, and L. Skladaný, “Circulating markers of liver fibrosis progression,” Clinica Chimica Acta, vol. 411, pp. 1009–1017, 2010. View at Publisher · View at Google Scholar
  4. L. Castera, X. Forns, and A. Alberti, “Non-invasive evaluation of liver fibrosis using transient elastography,” Journal of Hepatology, vol. 48, no. 5, pp. 835–847, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Nightingale, “Acoustic radiation force impulse (ARFI) imaging: a review,” Current Medical Imaging Reviews, vol. 7, no. 4, pp. 328–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Y. Kim, J. Y. Choi, C.-H. Park et al., “Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis,” Journal of Gastroenterology, vol. 48, no. 10, pp. 1180–1187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Haimerl, N. Verloh, F. Zeman et al., “Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI,” PLoS ONE, vol. 8, no. 12, Article ID e85658, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. B. B. Frericks, C. Loddenkemper, A. Huppertz et al., “Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA,” American Journal of Roentgenology, vol. 193, no. 4, pp. 1053–1060, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Saito, F. Kotake, N. Ito et al., “Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase,” Magnetic Resonance in Medical Sciences, vol. 4, no. 1, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. B.-B. Chen, C.-Y. Hsu, C.-W. Yu et al., “Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients,” European Radiology, vol. 22, no. 1, pp. 171–180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Berzigotti, J. G. Abraldes, P. Tandon et al., “Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis,” Journal of Hepatology, vol. 52, no. 6, pp. 846–853, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. A. Bluemke, D. Sahani, M. Amendola et al., “Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study,” Radiology, vol. 237, no. 1, pp. 89–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Weinmann, G. Schuhmann‐Giampieri, H. Schmitt‐Willich, H. Vogler, T. Frenzel, and H. Gries, “A new lipophilic gadolinium chelate as a tissue‐specific contrast medium for MRI,” Magnetic Resonance in Medicine, vol. 22, no. 2, pp. 233–237, 1991. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Schuhmann-Giampieri, H. Schmitt-Willich, W.-R. Press, C. Negishi, H.-J. Weinmann, and U. Speck, “Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system,” Radiology, vol. 183, no. 1, pp. 59–64, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. U. Motosugi, T. Ichikawa, M. Oguri et al., “Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: Comparison with aspartate aminotransferase-to-platelet ratio index,” Magnetic Resonance Imaging, vol. 29, no. 8, pp. 1047–1052, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Tsuda and O. Matsui, “Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi - Gadoxetic acid-enhanced MR imaging,” Radiology, vol. 256, no. 3, pp. 767–773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Tamada, K. Ito, A. Higaki et al., “Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers,” European Journal of Radiology, vol. 80, no. 3, pp. e311–e316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. F. T. C. Tschirch, A. Struwe, H. Petrowsky, I. Kakales, B. Marincek, and D. Weishaupt, “Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma,” European Radiology, vol. 18, no. 8, pp. 1577–1586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Wibmer, Q. Aliya, R. Steininger et al., “Liver transplantation: impaired biliary excretion of gadoxate is associated with an inferior 1-year retransplantation-free survival,” Investigative Radiology, vol. 47, no. 6, pp. 353–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Yamada, T. Hara, F. Li et al., “Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging,” Radiology, vol. 260, no. 3, pp. 727–733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Katsube, M. Okada, S. Kumano et al., “Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging,” Investigative Radiology, vol. 46, no. 4, pp. 277–283, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Tsuda, M. Okada, and T. Murakami, “Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging,” Investigative Radiology, vol. 42, no. 4, pp. 242–247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Kanki, T. Tamada, A. Higaki et al., “Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis,” Magnetic Resonance Imaging, vol. 30, no. 3, pp. 356–360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. K. I. Ringe, D. B. Husarik, C. B. Sirlin, and E. M. Merkle, “Gadoxetate disodium - enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver,” American Journal of Roentgenology, vol. 195, no. 1, pp. 13–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Materne, A. M. Smith, F. Peeters et al., “Assessment of hepatic perfusion parameters with dynamic MRI,” Magnetic Resonance in Medicine, vol. 47, no. 1, pp. 135–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Shimizu, K. Dono, M. Gotoh et al., “Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging,” Digestive Diseases and Sciences, vol. 44, no. 7, pp. 1330–1337, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Yoneyama, Y. Fukukura, K. Kamimura et al., “Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function,” European Radiology, vol. 24, no. 4, pp. 857–865, 2014. View at Publisher · View at Google Scholar · View at Scopus